Hints and tips:
...They join seven members of the current ESA astronaut corps selected for training in 2009....
...American pessimism I was very much struck by this interview in The New York Times with the Democratic pollster Brian Stryker....
...US medical device maker Stryker will buy smaller rival Wright Medical in a deal worth $5.4bn including debt as it seeks to boost its exposure to the fast-growing orthopaedics market....
...The orthopaedic implant maker’s 2020 operating profit slumped to $295m from $815m the year before....
...Twelve times 2021 ev/ebitda looks cheap versus 13.5 times for Zimmer and Stryker, they say: We are upgrading SN to Overweight as we believe the fundamentals of the business are less challenged compared...
...Besides Stryker, other leaders in the industry include Johnson & Johnson, which acquired orthopaedic device maker Synthes for $21.3bn in 2012, and Zimmer Biomet, which was formed by a $14bn takeover in 2014...
...(Tech Crunch) News round-up Silicon Valley fund seeks major stake in New York Knicks, Rangers (New York Post) British Airways group to buy Air Europa for €1bn (FT) US medical device maker Stryker to...
...He has installed presidents for each division — sports medicine; orthopaedics and wound management — in an attempt to sharpen execution in a sector marked by constant evolution....
...Boston Scientific shares jumped almost 10 per cent on Monday after a media report Stryker made an approach to purchase the rival maker of medical devices....
...Putting the orthopaedic devices or wound management businesses up for sale would likely attract interest from both industry buyers and private equity, while rivals including Stryker would likely want the...
...The Schoen Clinic, an orthopaedic hospital, is opening its first hospital outside Germany, with a seven-floor facility in London’s Wigmore Street due to start business in March next year....
...It spends half its revenues on general overhead; at US peer Stryker, the ratio is just over a third. The problem is partly scale....
...“[G]iven the consolidated and highly regulated nature of the mature orthopaedic space, we continue to see Stryker and (lesser so) Medtronic as the best suitors — not just from the regulatory angle (either...
...Stryker, the US device maker which four years ago disclosed it had been considering a bid for Smith & Nephew, has seen its own share price rise more than 20 per cent in the past year, for example....
...Stryker, which in 2014 disclosed that it had been working on a bid, was once again being mooted by day traders as a potential buyer....
...US rivals Stryker and Johnson & Johnson both have the capacity to bid....
...The company’s share price has more than doubled over the past five years but it has also underperformed some of its peers, such as Stryker, its larger US-based rival, which in 2014 disclosed that it had...
...Stryker trades at 22 times forward earnings. Intuitive Surgical at 39 times. Both, however, are valued far below technology company multiples and are already profitable....
...News round-up Stryker makes takeover approach to Boston Scientific (WSJ) KKR agrees to buy Envision Healthcare in $9.9bn deal (FT) USG Corp agrees to $7bn deal from Germany’s Knauf (FT) Mars to buy AniCura...
...The stake building comes after weeks of rumoured takeover interest in the UK medical device maker, which is often cited as a takeover target for US rivals Johnson & Johnson or Stryker, pushing the stock...
...On the same day, US medical device group Stryker also unveiled a $2.8bn deal to buy Sage, which makes products to prevent infections in hospitals....
...But S&N shares pared losses after Stryker management said on a post-acquisition conference call that the company “still has capacity to do more deals”, and flagged up orthopaedics as an area of interest....
...The company has been the subject of takeover speculation involving Stryker, a Fortune 500 medical technologies company based in Kalamazoo in Michigan....
...Also on Monday, medical device company Stryker agreed to buy Sage, which makes care products, for $2.8bn....
...Shares in Stryker , the medical device company, fell earlier in the day after it announced a deal to buy Sage Products, which makes care products, for $2.78bn. They closed almost flat....
International Edition